Runwell Hospital, Wickford, Essex
ABSTRACT
A double-blind cross-over trial of Haloperidol was conducted on twenty long-stay schizophrenic patients. The results are described in terms of rating scales, symptom responses and diagnosis. Toxic effects of Haloperidol are enumerated and their prevention discussed.